Lv3
316 积分 2024-04-17 加入
Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting
1个月前
已完结
Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis
1个月前
已完结
Systemic lupus erythematosus and damage: What has changed over the past 20 years?
1个月前
已完结
Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies
1个月前
已完结
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells
1个月前
已完结
Bruton Tyrosine Kinase Degraders: Current Concepts
3个月前
已完结
Novel mechanisms of resistance in CLL: variant BTK mutations in second-generation and noncovalent BTK inhibitors
3个月前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
4个月前
已完结
Evaluating orelabrutinib as a novel treatment option for relapsed/refractory chronic lymphocytic leukemia in China
4个月前
已完结
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts
4个月前
已关闭
皖公网安备34019202002308
